OncoMatch/Clinical Trials/NCT03810651
Pencil Beam Scanning in Patients With Renal Tumors
Is NCT03810651 recruiting? Yes, currently enrolling (Jun 2026). This Early Phase 1 trial studies non-drug interventions for renal tumor.
This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.
Check if I qualifyExtracted eligibility criteria
Disease stage
Required: Stage III
Demographics
Prior therapy
Cannot have received: radiation therapy
Cannot have received: chemotherapy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT03810651 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior radiation therapy, chemotherapy disqualifies patients from enrollment.
What disease stage is eligible?
Stage III is required.
Is there an age limit?
Yes. Patients must be 30 years or younger and at least 0 years old.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify